Loading publications…
The last 5 uploaded publications
DNA Methylation Profiling of Human Hepatocarcinogenesis
Gabriela Hernandez‐Meza, Johann von Felden, Edgar Gonzalez‐Kozlova, Teresa García‐Lezana, Judit Peix, Anna Portela, Amanda J. Craig, Sergi Sayols, Myron Schwartz, Bojan Losic, Vincenzo Mazzaferro, Manel Esteller, Josep M. Llovet, Augusto Villanueva (2020). DNA Methylation Profiling of Human Hepatocarcinogenesis. Hepatology, 74(1), pp. 183-199, DOI: 10.1002/hep.31659.
Article145 days agoUnannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer
Johann von Felden, Teresa García‐Lezana, Navneet Dogra, Edgar Gonzalez‐Kozlova, Mehmet Eren Ahsen, Amanda J. Craig, Stacey M. Gifford, Benjamin H. Wunsch, Joshua T. Smith, Sung‐Cheol Kim, Jennifer E. L. Diaz, Xintong Chen, Ismaïl Labgaa, Philipp K. Haber, Reena Olsen, Dan Han, Paula Restrepo, Delia D’Avola, Gabriela Hernandez‐Meza, Kimaada Allette, Robert Sebra, Behnam Saberi, Parissa Tabrizian, Amon Asgharpour, Douglas T. Dieterich, Josep M. Llovet, Carlos Cordon‐Cardo, Ash Tewari, Myron Schwartz, Gustavo Stolovitzky, Bojan Losic, Augusto Villanueva (2021). Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer. Gut, 71(10), pp. 2069-2080, DOI: 10.1136/gutjnl-2021-325036.
Article145 days agoTranscriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma
Amanda J. Craig, Teresa García‐Lezana, Marina Ruiz de Galarreta, Carlos Villacorta-Martín, Edgar Gonzalez‐Kozlova, Sebastiao N. Martins‐Filho, Johann von Felden, Mehmet Eren Ahsen, Erin Bresnahan, Gabriela Hernandez‐Meza, Ismaïl Labgaa, Delia D’Avola, Myron Schwartz, Josep M. Llovet, Daniela Sia, Swan N. Thung, Bojan Losic, Amaia Lujambio, Augusto Villanueva (2021). Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. PLoS Genetics, 17(6), pp. e1009589-e1009589, DOI: 10.1371/journal.pgen.1009589.
Article145 days agoSingle-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
Sarah Cappuyns, Marta Piqué‐Gili, Roger Esteban-Fabró, Gino Philips, Ugne Balaseviciute, Roser Pinyol, Albert Gris‐Oliver, Vincent Vandecaveye, Jordi Abril‐Fornaguera, Carla Montironi, Laia Bassaganyas, Judit Peix, Marcus Zeitlhöfler, Agavni Mesropian, Júlia Huguet‐Pradell, Philipp K. Haber, Igor Figueiredo, Giorgio Ioannou, Edgar Gonzalez‐Kozlova, Antonio D’Alessio, Raphael Mohr, Tim Meyer, Anja Lachenmayer, Jens U. Marquardt, Helen L. Reeves, Julien Edeline, Fabian Finkelmeier, Jörg Trojan, Peter R. Galle, Friedrich Foerster, Beatriz Mínguez, Robert Montal, Sacha Gnjatic, David J. Pinato, Mathias Heikenwälder, Chris Verslype, Eric Van Cutsem, Diether Lambrechts, Augusto Villanueva, Jeroen Dekervel, Josep M. Llovet (2024). Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma. Journal of Hepatology, DOI: 10.1016/j.jhep.2024.12.016.
Article145 days agoLBP-029-YI Spatial transcriptomics of the tumor microenvironment discriminates inflamed tumors responsive or resistant to atezolizumab + bevacizumab in patients with advanced HCC
Marta Piqué‐Gili, Anna Vila-Escoda, Marta Casado-Peláez, Roser Pinyol, Ana Hernández de Sande, Verónica Dávalos, Albert Gris‐Oliver, Carla Montironi, Judit Peix, Eduard Porta‐Pardo, Daniela Grases, Sarah Cappuyns, Ezequiel Mauro, Guillem Cano-Segarra, Igor Figueiredo, Giorgio Ioannou, Edgar Gonzalez‐Kozlova, Tim Meyer, Anja Lachenmayer, Jens U. Marquardt, Helen L. Reeves, Julien Edeline, Fabian Finkelmeier, Jörg Trojan, Jean–Frédéric Blanc, Richard Hubner, Matthias Pinter, Tom Luedde, Arndt Vogel, Sacha Gnjatic, Daniela Sia, Vincenzo Mazzaferro, Jeroen Dekervel, Manel Esteller, Josep M. Llovet (2025). LBP-029-YI Spatial transcriptomics of the tumor microenvironment discriminates inflamed tumors responsive or resistant to atezolizumab + bevacizumab in patients with advanced HCC. , 82, DOI: https://doi.org/10.1016/s0168-8278(25)00447-7.
Article76 days ago